Cite

HARVARD Citation

    Marastoni, D. et al. (2019). 174 Sclerosing dermopathy after alemtuzumab for multiple sclerosis. Journal of neurology, neurosurgery and psychiatry. 90 (12), p. e46. [Online]. 
  
Back to record